About US

We pledge to provide a medical home for persons affected by lysosomal and rare disorders

About us

About our Journey

LTC was founded in 2013 by Dr. Ozlem Goker-Alpan with a vision to provide high quality care for individuals with lysosomal storage diseases and other rare genetic disorders.  Dr. Ozlem Goker-Alpan is a world-renowned authority in the field of lysosomal and other rare genetic disorders and is well known for her dedication to the health and well-being of her patients and families.

Mission & VIsion

We use the latest research to unravel underlying disease-causing mechanisms, discover new biomarkers, and explore new therapeutic pathways and treatment options for persons suffering from lysosomal and other rare disease.

LTC utilizes a variety of clinical treatment and research protocols and offers compassionate care and platform for the patients and families affected by these debilitating disorders.

Your Medical Home for
Lysosomal Storage Disorders (LSDs)

We are a medical home and provide comprehensive medical care for individuals with various LSDs nationwide and internationally. For patients of all ages, we offer:

  • Genetics testing
  • Coordination of treatment via enzyme replacement therapy (ERT) and other approved therapies
  • Participation in research studies and disease registries
  • Coordination of multidisciplinary care
  • Continuity of care and long term follow-up
  • Support and education for patients and their families
  • Clinical identification and biochemical and molecular diagnoses for LSDs
  • In-house treatment with different enzyme replacement products
  • Management of patients who cannot tolerate ERT due to immune reactions and neutralizing antibodies

In our Rare Disease Clinic, we offer extensive medical genetic evaluations for complex medical problems of unknown etiology and that do not fit a particular disease pattern. Our clinical evaluation begins with an experienced provider who takes a detailed medical history and an extensive three generation family history. Then, a comprehensive physical exam, including a detailed dysmorphology, and neurological examination, is followed by “traditional tier-wise” genetic testing and directed molecular or cytogenetic testing.


Ozlem Goker-Alpan, MD
FounderOzlem Goker-Alpan, MD
Dr. Ozlem Goker-Alpan is the founder and CEO of LDRTC. Dr. Goker-Alpan founded LDRTC in 2013 with a vision to provide high quality care for individuals with lysosomal storage disorders and other rare diseases by utilizing a variety of clinical treatment protocols, multi-specialty clinics and research protocols. She received her MD degree in 1990 from Marmara University School of Medicine in Istanbul, Turkey with the highest honors as first in her class. She trained in Pediatrics and then served as a Pediatric Chief Resident at SUNY at Stony Brook, New York. She completed her first fellowship in Clinical and Biochemical Genetics at the National Institutes of Health, Greater Washington Medical Genetics Program in 1999, and worked as an adjunct scientist at the National Child Health Institute. Her second fellowship focused on Lysosomal Storage Disorders and Gaucher disease at the Clinical Neuroscience Branch, NIMH. She coordinated the NIH Gaucher Clinic at the Medical Genetics Branch of the National Human Genome Research Institute until her departure from the NIH in December, 2009.
Uyensa Beese
Office ManagerUyensa Beese
Uyensa Beese acts as Patient Liaison officer and is highly involved in facilitating patients’ visits to the treatment center and offering support to the affected families. She holds B.S. degree in Business from the GMU and has experience as Patient Liaison in the clinical set up since 2011.

Connect with us

3702 Pender Drive, Suite 170,
Fairfax VA 22030

  • Phone 1 703-261-6220

  • Fax 1 703 991-6592

  • info@LDRTC.org